Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients.
about
Trial watch: Dendritic cell-based anticancer therapySurvivin, a molecular target for therapeutic interventions in squamous cell carcinoma.Interaction of dendritic cells and T lymphocytes for the therapeutic effect of Dangguiliuhuang decoction to autoimmune diabetes.Dendritic cell vaccines targeting survivin in head and neck cancer.
P2860
Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Exploring dendritic cell based ...... head and neck cancer patients.
@en
type
label
Exploring dendritic cell based ...... head and neck cancer patients.
@en
prefLabel
Exploring dendritic cell based ...... head and neck cancer patients.
@en
P2093
P2860
P356
P1476
Exploring dendritic cell based ...... head and neck cancer patients
@en
P2093
Annelies W Turksma
C René Leemans
Chris J L M Meijer
Hetty J Bontkes
Janneke J Ruizendaal
Johanneke Akershoek
Kirsten B J Scholten
Laura M Moesbergen
Saskia A G M Cillessen
Saskia J A M Santegoets
P2860
P2888
P356
10.1186/1479-5876-11-152
P577
2013-06-20T00:00:00Z
P5875
P6179
1016893373